EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD

Xavier Palomer, Jue-Rui Wang, Claudia Escalona, Siyuan Wu, Walter Wahli, Manuel Vázquez-Carrera

Trends in Pharmacological Sciences · 2025-06 · 46 (6) · 551-566

DOI: 10.1016/j.tips.2025.03.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2025-06. Verfasst von Xavier Palomer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology, and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, S…. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Universitat de Barcelona, European Regional Development Fund, Ministerio de Ciencia, Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesLiver CirrhosisNon-alcoholic Fatty Liver DiseaseFatty LiverHumansAnimals

Stichwörter der Autor:innen

MASHapoptosishepatic stellate cellsinflammationmetformin

Substanzen

AMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Pharmacology, Toxicology, and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain; Institute of Biomedicine of the University of Barcelona (IBUB),…
  • Center for Integrative Genomics, University of Lausanne, CH-1015 Lausanne, Switzerland; ToxAlim (Research Center in Food Toxicology), Institut National de Recherche pour l'Agriculture, l'Alimentation, et l'Environnement…

Förderung

  • Universitat de Barcelona
  • European Regional Development Fund
  • Ministerio de Ciencia, Innovación y Universidades
  • Instituto de Salud Carlos III
  • Center for International Business Education and Research, University of Illinois at Urbana-Champaign
  • Ministerio de Ciencia e Innovación

Zitieren

APA

Palomer, X., Wang, J. R., Escalona, C., Wu, S., Wahli, W., & Vázquez-Carrera, M. (2025). Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD. Trends in Pharmacological Sciences, 46(6), 551-566. https://doi.org/10.1016/j.tips.2025.03.008

Vancouver

Palomer X, Wang JR, Escalona C, Wu S, Wahli W, Vázquez-Carrera M. Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD. Trends in Pharmacological Sciences. 2025;46(6):551-566. doi:10.1016/j.tips.2025.03.008

BibTeX
@article{Palomer2025,
  author = {Palomer, Xavier and Wang, Jue-Rui and Escalona, Claudia and Wu, Siyuan and Wahli, Walter and Vázquez-Carrera, Manuel},
  title = {Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD},
  journal = {Trends in Pharmacological Sciences},
  year = {2025},
  volume = {46},
  number = {6},
  pages = {551--566},
  doi = {10.1016/j.tips.2025.03.008}
}
Kostenlos starten →